Pfizer and Valneva have been collaborating on VLA15’s development and commercialization since April 2020
Call it a major milestone in bladder cancer therapy that aims to provide a lifeline for patients who previously had limited options
The approvals target adult MIBC patients who are ineligible for cisplatin-based chemotherapy
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
Sales from Novo’s GLP-1 portfolio—including Wegovy for obesity and Ozempic for type 2 diabetes reached $5.6 billion
The discussions come as part of the administration’s broader efforts to drive down drug prices and increase patient access to essential therapies
Capvaxive has recorded $530 million in cumulative sales over its first four quarters on the market
The submissions are supported by data from the Phase 3 KEYNOTE-905 trial
XTANDI is the first and only androgen receptor inhibitor-based regimen to demonstrate overall survival benefit in this patient population, supporting its earlier use in this setting
AstraZeneca to invest $50bn in manufacturing and R&D to support domestic sourcing
Subscribe To Our Newsletter & Stay Updated
